A 2023 biotech breakthrough: CRISPR gene-editing therapy offers new hope for 100,000 Americans with sickle cell. Hear from CASGEVY's creators and patient advocates in this episode.
Biotech tackles climate change with innovations, from carbon-neutral facilities to reducing emissions. At COP28, BIO highlighted that biotech is key to climate tech.
Editing Cells Within the Body—a New CRISPR Frontier
CRISPR, biotech's rising star, reached a 2023 milestone with FDA approval for a sickle cell treatment. This episode explores the future of in-body gene editing with two pioneering companies.
Listener takeover: Your Biotech Questions Answered
In this episode, experts answer your questions on GMO safety, personalized medicine, feeding the world by 2050, and what attracts investors to start-ups.
Biotech companies are addressing climate change through innovation—from carbon neutral facilities to agricultural innovations to reduce greenhouse gas emissions. BIO was on the ground at the COP28 UN Climate Change Conference in Dubai to deliver the message that biotech is climate tech.